Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

1,000 lupus patients join hunt for skin disease genes

NCT ID NCT01266915

First seen Jan 04, 2026 · Last updated Jun 19, 2026 · Updated 32 times

Summary

This study aims to collect genetic and protein data from 1,000 people with cutaneous lupus (skin lupus) to better understand what causes it. Researchers hope to find specific genes and proteins that could lead to improved diagnosis and new drug development. Participants must be 18 or older and diagnosed with lupus.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas Southwestern Medical Center Dallas

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could identify key genes and proteins involved in cutaneous lupus, paving the way for better diagnostic tools and new treatments.

What could go wrong

This is an observational study, not a treatment trial. It may not directly benefit participants, and genetic findings may take years to translate into therapies.

Conditions

The condition(s) this trial relates to.

lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.